Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)
John P. DeVincenzo(University of Tennessee Health Science Center), Jeff Cehelsky(Alnylam Pharmaceuticals (United States)), Rene Alvarez(Alnylam Pharmaceuticals (United States)), Sayda M. Elbashir(Alnylam Pharmaceuticals (United States)), Jens Harborth(Alnylam Pharmaceuticals (United States)), Iva Toudjarska(Alnylam Pharmaceuticals (United States)), Lubomir V. Nechev(Alnylam Pharmaceuticals (United States)), Veeravagu Murugaiah(Alnylam Pharmaceuticals (United States)), A L van Vliet, Akshay Vaishnaw(Alnylam Pharmaceuticals (United States))
Cited by 246
Abstract
Related Papers
No related papers found
Powered by citation graph analysis